The Center for Fetal Diagnosis and Treatment advances the field after the MOMS trial set a new standard of care.
CHOP scientists altered red blood cells to produce a form of hemoglobin not affected by the mutation that causes sickle cell disease. The findings may lead to a new therapy for the disease.
Melissa's legacy lives on through a fund dedicated to improving the lives of underserved children in Africa.
Child Life Specialists at CHOP help ease the fears and anxiety of young patients through play.
CHOP’s plans to develop a human milk bank to serve hospitalized infants received widespread regional media attention.
A new study indicates rare night eating disorder may signal other mental health issues
Ten-month-old Madelyn Selley has been in CHOP’s N/IICU for seven months receiving expert care for chronic lung disease. Fox 29 recently visited the N/IICU to meet Maddy and her care team.
A personalized immunotherapy has been awarded the FDA's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia.